Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B
| File | Size | Format | |
|---|---|---|---|
| 63925_1.pdf | 538Kb | Adobe PDF | View |
| Title | Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B |
|---|---|
| Author | Davenport, Victoria; Groves, Eleanor; Horton, Rachel Elizabeth; Hobbs, Christopher G.; Guthrie, Terry; Findlow, Jamie; Borrow, Ray; Næss, Lisbeth M.; Oster, Philipp; Heyderman, Robert S.; Williams, Neil A. |
| Journal Name | Journal of Infectious Diseases |
| Year Published | 2008 |
| Place of publication | United States |
| Publisher | University of Chicago Press |
| Abstract | BACKGROUND: Nasopharyngeal carriage of meningococcus or related species leads to protective immunity in adolescence or early adulthood. This natural immunity is associated with mucosal and systemic T cell memory. Whether parenteral Neisseria meningitidis serogroup B (MenB) vaccination influences natural mucosal immunity is unknown. OBJECTIVES: To determine whether parenteral MenB vaccination affects mucosal immunity in young adults and whether this immunity differs from that induced in the blood. METHODS: Otherwise healthy volunteers were immunized with MenB outer membrane vesicle vaccine before and after routine tonsillectomy. Mucosal and systemic immunity were assessed in 9 vaccinees and 12 unvaccinated control subjects by measuring mononuclear cell proliferation, cytokine production, Th1/Th2 surface marker expression, and antibody to MenB antigens. RESULTS: Parenteral vaccination induced a marked increase in systemic T cell immunity against MenB and a Th1 bias. In contrast, although mucosal T cell proliferation in response to MenB neither increased nor decreased following vaccination, mononuclear cell interferon gamma, interleukin (IL)-5, and IL-10 production increased, and the Th1/Th2 profile lost its Th1 bias. CONCLUSIONS: Parenteral MenB vaccination selectively reprograms preexisting naturally acquired mucosal immunity. As new-generation protein-based MenB vaccine candidates undergo evaluation, the impact of these vaccines on mucosal immunity in both adults and children will need to be addressed. |
| Peer Reviewed | Yes |
| Published | Yes |
| Alternative URI | http://dx.doi.org/10.1086/590669 |
| Copyright Statement | Copyright 2008 by University of Chicago Press. The attached file is reproduced here in accordance with the copyright policy of the publisher. First published in Journal of Infectious Diseases, 2008;198:731–740. Please refer to the journal's website for access to the definitive, published version. |
| Volume | 198 |
| Issue Number | 5 |
| Page from | 731 |
| Page to | 740 |
| ISSN | 0022-1899 |
| Date Accessioned | 2010-07-16 |
| Date Available | 2010-11-05T08:06:44Z |
| Language | en_AU |
| Faculty | Faculty of Science, Environment, Engineering and Technology |
| Subject | Immunology |
| URI | http://hdl.handle.net/10072/34913 |
| Publication Type | Journal Articles (Refereed Article) |
| Publication Type Code | c1x |
Please use this identifier to cite this record: http://hdl.handle.net/10072/34913
Griffith University copyright notice
Copyright in individual works within the repository belongs to their authors or publishers. You may make a print or digital copy of a work for your personal non-commercial use. All other rights are reserved, except for fair dealings or other user rights granted by the copyright laws of your country.
Back to top